Company
United StatesPublic company, OTC: LNXSYLANXESS Corporation (OTC: LNXSY), Kalama, WA – FDA Inspections
Inspection records and compliance data for LANXESS Corporation in Kalama, WA. 8 FDA inspections on record, 1 Form 483, last inspected September 12, 2024. Publicly traded as OTC: LNXSY.
Company Profile
This profile covers LANXESS Corporation based in Kalama, WA, United States.
FDA Inspection History
- FDA inspections
- 8
- OAI
- 0
- VAI
- 2
- NAI
- 3
- Unclassified
- 3
- Form 483s
- 1
- Warning letters
- 0
First inspected November 6, 2008. Last inspected September 12, 2024.
FDA inspections (8)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 12, 2024 | Not classified | Human Drugs | 1249142 |
| April 14, 2023 | Not classified | Foods & Cosmetics | 1203652 |
| April 10, 2018 | Not classified | Foods & Cosmetics | 1050575 |
| January 15, 2016 | VAI | Human Drugs · Drug Quality Assurance | 961641 |
| December 5, 2013 | NAI | Foods & Cosmetics · Foodborne Biological Hazards | 858227 |
| August 2, 2013 | NAI | Human Drugs · Drug Quality Assurance | 843254 |
| December 17, 2009 | VAI | Human Drugs · Drug Quality Assurance | 637142 |
| November 6, 2008 | NAI | Human Drugs · Drug Quality Assurance | 547074 |
FDA documents
People (5)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
LANXESS Corporation
Stock ticker
LNXSY
Exchange
OTC
Price as of
November 13, 2026
FEI Number
3022820
Address
1296 Nw 3rd St, Kalama, WA 98625-9701, United States
Country
United States
ID: d4d93912-8e03-47f0-87e8-1aac96f0a44d